Vortrag

Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL

Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL

Veranstaltungen

04.12.17

16:15 – 17:15

Jena

Jena

Dr. A. Marzinzik

Novartis Institutes for Biomedical Research, Basel/Schweiz

Kontaktperson


Zu Ihrem Kalender hinzufügen

Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
In andere Kalender herunterladen

Veranstaltungsdetails

04.12.17

16:15 – 17:15

Jena

Jena

Dr. A. Marzinzik

Novartis Institutes for Biomedical Research, Basel/Schweiz


Kontaktperson


Zu Ihrem Kalender hinzufügen

Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
Towards the goal of curing CML: discovery of ABL001 a novel allosteric inhibitor of BCR-ABL
In andere Kalender herunterladen